Promising advances in gene therapy for Huntington's disease

Autor: Josu Galarza La enfermedad de Huntington es un trastorno neurodegenerativo clasificado como enfermedad rara, con una incidencia de entre 5 y 10 casos por cada 100.000 habitantes. De carácter hereditario, sus principales manifestaciones clínicas son los movimientos involuntarios, así como alteraciones cognitivas y psiquiátricas. La presencia de agregados proteicos tóxicos en el cerebro, junto […]

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry

A team of researchers led by the University of Zaragoza has identified five proteins in cerebrospinal fluid (CSF) that could act as early biomarkers for the diagnosis of prion diseases, before the first clinical symptoms appear. The study, carried out in sheep with scrapie - a natural model of these neurodegenerative pathologies - used advanced mass spectrometry and ELISA techniques to analyse the alterations in the CSF proteome.

en_GBEnglish (UK)